Onward Medical N.V. (BR:ONWD) — Market Cap & Net Worth
Market Cap & Net Worth: Onward Medical N.V. (ONWD)
Onward Medical N.V. (BR:ONWD) has a market capitalization of $200.59 Million (€171.58 Million) as of June 17, 2026. Listed on the BR stock exchange, this Belgium-based company holds position #16638 globally and #71 in its home market, demonstrating a -4.54% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Onward Medical N.V.'s stock price €2.63 by its total outstanding shares 69528511 (69.53 Million). Review ONWD total debt and obligations to assess the company's total debt and financial obligations.
Onward Medical N.V. Market Cap History: 2021 to 2026
Onward Medical N.V.'s market capitalization history from 2021 to 2026. Data shows change from $829.12 Million to $213.78 Million (-28.75% CAGR).
Index Memberships
Onward Medical N.V. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
BEL Small
BELS
|
$5.85 Billion | 3.43% | #12 of 20 |
|
BEL All Share
BSPT
|
$854.21 Billion | 0.02% | #76 of 108 |
Weight: Onward Medical N.V.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Onward Medical N.V. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Onward Medical N.V.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
96.45x
Onward Medical N.V.'s market cap is 96.45 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $829.12 Million | $1.22 Million | -$34.31 Million | 680.16x | N/A |
| 2022 | $505.60 Million | $2.08 Million | -$32.77 Million | 243.55x | N/A |
| 2023 | $251.99 Million | $532.00K | -$36.18 Million | 473.66x | N/A |
| 2024 | $421.06 Million | $77.00K | -$35.73 Million | 5468.34x | N/A |
| 2025 | $364.57 Million | $3.78 Million | -$41.79 Million | 96.45x | N/A |
Competitor Companies of ONWD by Market Capitalization
Companies near Onward Medical N.V. in the global market cap rankings as of June 17, 2026.
Key companies related to Onward Medical N.V. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #442 globally with a market cap of $63.33 Billion USD.
- UCB SA (BR:UCB): Ranked #550 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #574 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $453.17 |
| #442 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $63.33 Billion | $614.73 |
| #550 | UCB SA | BR:UCB | $49.68 Billion | €250.00 |
| #574 | Argen-X | BR:ARGX | $47.14 Billion | €755.80 |
Onward Medical N.V. Historical Marketcap From 2021 to 2026
Between 2021 and today, Onward Medical N.V.'s market cap moved from $829.12 Million to $ 213.78 Million, with a yearly change of -28.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €213.78 Million | -41.36% |
| 2025 | €364.57 Million | -13.42% |
| 2024 | €421.06 Million | +67.10% |
| 2023 | €251.99 Million | -50.16% |
| 2022 | €505.60 Million | -39.02% |
| 2021 | €829.12 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Onward Medical N.V. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $200.59 Million USD |
| MoneyControl | $200.59 Million USD |
| MarketWatch | $200.59 Million USD |
| marketcap.company | $200.59 Million USD |
| Reuters | $200.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Onward Medical N.V.
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people wit… Read more